University Of Turku

Progressive multiple sclerosis

The clinical research activity is centered on progressive multiple sclerosis, with attention to smoldering inflammation and disease-related changes within the central nervous system. The focus includes inflammatory activity in cerebral white matter and the biological processes associated with ongoing neurological decline.

  • Multiple sclerosis
  • Progressive disease
  • Neuroinflammation
  • White matter pathology

Research activity in this area is linked to imaging-based assessment of inflammatory burden in the brain, supporting investigation of disease mechanisms in patients with progressive forms of MS.

Neuroimaging and brain inflammation

The sponsor’s trial portfolio includes positron emission tomography approaches used to examine inflammatory activity in the brain, with emphasis on TSPO-PET imaging and voxel-level changes in cerebral tissue. This area reflects interest in mapping inflammatory signals within white matter while excluding established lesion regions.

  • TSPO-PET
  • Positron emission tomography
  • Cerebral white matter
  • Voxel-based imaging

The imaging focus supports detailed evaluation of inflammatory activity in relation to progressive neurological disease.

Neurology and therapeutic modulation

Clinical interest extends to neurology with a therapeutic emphasis on modifying inflammatory pathways relevant to demyelinating disease. The funded research explores treatment effects in patients with progressive neurological impairment, highlighting interest in interventions aimed at reducing ongoing inflammatory activity.

  • Neurological disease
  • Demyelination
  • Inflammatory modulation
  • Disability progression

This therapeutic domain is closely tied to the search for disease-relevant biological changes that may be measurable in the brain.

Clinical neuroscience

The sponsor’s research landscape sits within clinical neuroscience, combining disease-focused brain imaging with therapeutic evaluation in a progressive neurological condition. The work involves collaboration across multiple research sites in Finland, supporting clinical investigation in a specialized academic setting.

  • Clinical neuroscience
  • Academic medicine
  • Multisite collaboration
  • Neurological inflammation

The main medical interest remains centered on understanding and measuring inflammatory disease activity in progressive MS.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Istradefylline for Reducing Brain Inflammation in Patients with Progressive Multiple Sclerosis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Finland